IT1400609B1 - Associazione di inibitori della xantina ossidasi e metformina e loro uso. - Google Patents
Associazione di inibitori della xantina ossidasi e metformina e loro uso.Info
- Publication number
- IT1400609B1 IT1400609B1 ITRM2010A000233A ITRM20100233A IT1400609B1 IT 1400609 B1 IT1400609 B1 IT 1400609B1 IT RM2010A000233 A ITRM2010A000233 A IT RM2010A000233A IT RM20100233 A ITRM20100233 A IT RM20100233A IT 1400609 B1 IT1400609 B1 IT 1400609B1
- Authority
- IT
- Italy
- Prior art keywords
- xanthin
- metformin
- association
- oxidase
- inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM2010A000233A IT1400609B1 (it) | 2010-05-10 | 2010-05-10 | Associazione di inibitori della xantina ossidasi e metformina e loro uso. |
TW100116121A TW201206431A (en) | 2010-05-10 | 2011-05-09 | Association of xanthine oxidase inhibitors and metformin and use thereof |
PCT/EP2011/057412 WO2011141419A1 (en) | 2010-05-10 | 2011-05-09 | Association of the xanthine oxidase inhibitor febuxostat and metformin and use thereof |
ARP110101591A AR081024A1 (es) | 2010-05-10 | 2011-05-09 | Asociacion de los inhibidores de la xantina oxidasa y la metformina y su uso |
CR20120617A CR20120617A (es) | 2010-05-10 | 2012-12-06 | Combinación de inhibidores de xantna oxidasa y antagonistas del receptor de angiotensina ii y su uso |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM2010A000233A IT1400609B1 (it) | 2010-05-10 | 2010-05-10 | Associazione di inibitori della xantina ossidasi e metformina e loro uso. |
Publications (2)
Publication Number | Publication Date |
---|---|
ITRM20100233A1 ITRM20100233A1 (it) | 2011-11-11 |
IT1400609B1 true IT1400609B1 (it) | 2013-06-14 |
Family
ID=43519819
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITRM2010A000233A IT1400609B1 (it) | 2010-05-10 | 2010-05-10 | Associazione di inibitori della xantina ossidasi e metformina e loro uso. |
Country Status (5)
Country | Link |
---|---|
AR (1) | AR081024A1 (it) |
CR (1) | CR20120617A (it) |
IT (1) | IT1400609B1 (it) |
TW (1) | TW201206431A (it) |
WO (1) | WO2011141419A1 (it) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113164439A (zh) * | 2018-12-06 | 2021-07-23 | 安索治疗公司 | 用于治疗或预防痛风或高尿酸血症的方法 |
WO2024033705A1 (en) * | 2022-08-08 | 2024-02-15 | Xortx Therapeutics, Inc. | Xanthine oxidase inhibitor formulations |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU645867B2 (en) | 1990-11-30 | 1994-01-27 | Teijin Pharma Limited | 2-arylthiazole derivative and pharmaceutical composition containing the same |
EP1020454B2 (en) | 1998-06-19 | 2013-01-23 | Teijin Pharma Limited | Polymorphic modifications of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazole-carboxylic acid and processes for the preparation thereof |
US20040122067A1 (en) | 2002-12-20 | 2004-06-24 | Lin Zhao | Treatment of chronic heart failure |
JP5242393B2 (ja) | 2005-08-03 | 2013-07-24 | タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド | 高血圧症の治療方法 |
CA2630639A1 (en) | 2005-11-21 | 2007-05-31 | Tap Pharmaceutical Products, Inc. | Treatment of qt interval prolongation and diseases associated therewith |
KR20160031040A (ko) | 2006-11-13 | 2016-03-21 | 다케다 파마슈티칼스 유에스에이, 인코포레이티드 | 크산틴 옥시도리덕타아제 억제제를 사용하여 신장 기능을 보존하는 방법 |
US20100305074A1 (en) * | 2007-04-04 | 2010-12-02 | Hight H Thomas | Niacin-based pharmaceutical compositions |
US20100137289A1 (en) * | 2007-04-17 | 2010-06-03 | Johnson Richard J | Methods and Compositions for Ameliorating Thiazide Induced Hyperlipidemia |
-
2010
- 2010-05-10 IT ITRM2010A000233A patent/IT1400609B1/it active
-
2011
- 2011-05-09 WO PCT/EP2011/057412 patent/WO2011141419A1/en active Application Filing
- 2011-05-09 AR ARP110101591A patent/AR081024A1/es unknown
- 2011-05-09 TW TW100116121A patent/TW201206431A/zh unknown
-
2012
- 2012-12-06 CR CR20120617A patent/CR20120617A/es unknown
Also Published As
Publication number | Publication date |
---|---|
ITRM20100233A1 (it) | 2011-11-11 |
CR20120617A (es) | 2013-03-04 |
TW201206431A (en) | 2012-02-16 |
AR081024A1 (es) | 2012-05-30 |
WO2011141419A1 (en) | 2011-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2020025I1 (el) | Αναστολεις βητα-λακταμασων | |
SMT201600135B (it) | Nuovi inibitori della s-nitrosoglutatione riduttasi | |
DK2536722T3 (da) | Bicycliske forbindelser og deres anvendelse som dual-c-src-/jak-inhibitorer | |
SMT201600021B (it) | Nuovi composti di chinolina sostituiti come inibitori della s-nitrosoglutatione reduttasi | |
CY2019026I1 (el) | Μη νουκλεοσιδικοι αναστολεις αναστροφης μεταγραφασης | |
SMT201600023B (it) | Composti piridazinonici e loro uso come inibitori di daao | |
SMT201600311B (it) | Inibitori di cdk | |
SMT201500271B (it) | Inibitori di neprilisina | |
BR112013025354A2 (pt) | combinações de compostos de inibidor de akt e agentes quimioterápicos e métodos de uso | |
ECSP13012394A (es) | Nuevas formas de dosificación de liberación modificada de un inhibidor de la xantina oxidorreductasa o de inhibidores de xantina oxidasa | |
DK3590934T3 (da) | Pyrazolylquinoxalinkinasehæmmere | |
DOP2012000114A (es) | Inhibidor bromodominio de benzodiazepina | |
DK2421825T3 (da) | Azetidinyldiamider som monoacylglycerollipase-inhibitorer | |
CO6930362A2 (es) | Compuesto heterocíclico y su uso | |
DK2389352T3 (da) | Arginaseinhibitorer og anvendelsesfremgangsmåder | |
DK2504332T4 (da) | Amorf form og krystallinsk form af genz 112638-hemitartrat som inhibitor af glucosylceramidsyntase | |
DK2513105T3 (da) | 2-arylimidazolderivater som pde10a-enzyminhibitorer | |
CO7020907A2 (es) | Inhibidores de quinurenina-3-monooxigenasa, composiciones farmacéuticas y métodos de uso de los mismos | |
DK2483271T3 (da) | Pyrazolindionderivater som NADPH-oxidaseinhibitorer | |
BR112013013523A2 (pt) | centralizador, método, e, uso de um centralizador | |
BRPI1007494A2 (pt) | composto e uso do mesmo | |
DOP2011000397A (es) | Nuevos derivados de fenilimidazol como inhibidores de la enzima pde10a | |
DK2513106T3 (da) | Heteroaromatiske aryltriazol-derivater som pde10a-enzyminhibitorer | |
DK3597650T3 (da) | Aldosereduktasehæmmere og anvendelser deraf | |
BR112013006131A2 (pt) | inibidores de notum pectinacetilesterase e métodos para sua utilização |